Source: Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.
Aller á la Source
Nouvelles connexes
List des news
Source: Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.